Trastuzumab deruxtecan shows early promise in patients with non-breast/gastric cancers
A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki, showed signs of clinical activity in multiple non-breast/non-gastric cancer…
Browsing: trastuzumab deruxtecan